Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer: a Registry-based Randomized Clinical Trial - SWE-Switch Breast Cancer Trial

NCT06223698 is registered in ClinicalTrials.gov with Region Örebro County as lead sponsor.

NCT NCT06223698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer: a Registry-based Randomized Clinical Trial - SWE-Switch Breast Cancer Trial
Lead sponsor
Region Örebro County
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 2, 2025
Completion date
May 2, 2035
Enrollment
3,832 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer